Peripheral blood CD26 leukaemia stem cell monitoring in CML during TKI treatment

Bookmark and Share
Published: 8 Dec 2020
Views: 109
Rating:
Save
Prof Monica Bocchia - University of Siena, Siena, Italy

Prof Monica Bocchia speaks to ecancer in an online interview for the virtual ASH 2020 meeting about the interim results of the PROSPECTIVE FLOWERS study.

The multicentre prospective study looked at peripheral blood CD26 leukaemia stem cell monitoring in chronic myeloid leukaemia patients during TKI treatment. 

This program is funded in part via an independent grant from AbbVie. ecancer is editorially independent and there is no influence over content.